EP3785733
Lyfjasamsetning til meðferðar við einhverfu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.11.2018EP published:
5.1.2022EP application number:
20195373.4
EP translation filed:
31.3.2022Grant published:
15.5.2022EPO information:
European Patent Register
Max expiry date:
5.11.2038Expiry date:
5.11.2025Next due date:
30.11.2025
Title in English:
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISMLanguage of the patent:
English
Timeline
Today
6.11.2018EP application
5.1.2022EP Publication
31.3.2022Translation submitted
15.5.2022Registration published
5.11.2025Expires
Owner
Name:
Stalicla S.A.Address:
Avenue de Sécheron 15, 1202 Geneva, CH
Inventor
Name:
Durham, LynnAddress:
1202 Genève, CH
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201762582141 PDate:
6.11.2017Country:
US
Number:
17200219Date:
6.11.2017Country:
EP
Number:
201862663647 PDate:
27.4.2018Country:
US
Number:
18169952Date:
27.4.2018Country:
EP
Classification
Categories:
A61K 45/00, A61P 25/00, A61K 31/196, A61K 31/437
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 11.11.2022
Expires: 5.11.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 5
Paid: 11.11.2022
Expires: 5.11.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 6
Paid: 10.11.2023
Expires: 5.11.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 6
Paid: 10.11.2023
Expires: 5.11.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 12.11.2024
Expires: 5.11.2025
Payer: G.H. Sigurgeirsson ehf.